CB2 Insights Introduces Insurable Medical Services to Patients in the United States with Launch of Skylight Health Group

NEXT STORY
Rubius Therapeutics Announces Preclinical Data from Red Cell Therapeutic Oncology Programs to be Presented at the ASGCT 23rd Annual Meeting
PREV STORY
TG Therapeutics Bolsters Board of Directors with the Appointment of Sagar Lonial, MD
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a company of the Menarini Group, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region

author_avatar
NASDAQ Market News

SOTIO Announces First Patient Dosed in Part B of Phase 1/1b Study with SO-C101 in Combination with Pembrolizumab in Patients with Solid Tumors

author_avatar
NASDAQ Market News

GILEAD AND GALAPAGOS TO PRESENT NEW DATA ON FILGOTINIB AT 2019 ACR/ARP ANNUAL MEETING

author_avatar
NASDAQ Market News